Menquadfi vial 0.5ML
Ended Awarded
- Contract number
- SPE2DR26FNL8Q
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $7,035
Award facts
- Contract value 100% obligated
- $7,035.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 31, 2025, for the supply of Menquadfi vial (0.5mL) with a ceiling value of $7,035.30. This firm fixed-price delivery order, which must be completed by November 3, 2025, is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The award was made through open competition with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor and healthcare solutions provider for federal medical procurement, particularly supporting military and veteran healthcare systems.
This delivery order supports AmerisourceBergen Drug Corp's ongoing role as a pharmaceutical prime vendor under the DLA's global medical supply chain. The company's comprehensive IDC vehicle enables it to supply a vast range of pharmaceutical products and medical supplies—including specialty medications, brand-name and generic drugs, vaccines, and medical devices—to support military healthcare programs worldwide. As a child contract under the larger SPE2DX vehicle, this order leverages the established relationship between AmerisourceBergen and DLA to fulfill specific pharmaceutical requirements for Defense Health Agency and other federal healthcare system customers.
Quick answers
Who was awarded contract SPE2DR26FNL8Q?
SPE2DR26FNL8Q was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 31, 2025.
How much is contract SPE2DR26FNL8Q worth?
The government has obligated $7,035 on SPE2DR26FNL8Q.
Is contract SPE2DR26FNL8Q an order under another contract?
Yes. SPE2DR26FNL8Q is a delivery order under SPE2DR25D1021, an indefinite delivery contract.
Was contract SPE2DR26FNL8Q competed?
The extent of competition for SPE2DR26FNL8Q was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award